CVVIF yields 31.45% · PFE yields 6.13%● Live data
📍 CVVIF pulled ahead of the other in Year 1
Combined, CVVIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CVVIF + PFE for your $10,000?
Sociedad Comercial del Plata S.A. operates in construction, energy, transportation, and real estate sectors in Argentina and internationally. The company operates through Construction, Oil, Agribusiness, and Entertainment segments. It provides construction materials, such as bricks, tiles, floors and coatings, ceramics, porcelain tiles, and glasses for the construction industry. The company also engages in the development, exploration, and production of hydrocarbons, as well as trunk transportation of gas. In addition, the company offers omega grains; offers rail freight services for transporting grains from the humid pampas to the port; and invests in own securities, real estate development projects, and forestry. Further, it processes crude oil; markets fuels, lubricants, greases, and asphalt; and offers fuel storage and dock services. Additionally, the company manufactures frozen pre-fried potatoes; and operates amusement parks, theatres, and water parks. Sociedad Comercial del Plata S.A. was incorporated in 1927 and is based in Buenos Aires, Argentina.
Full CVVIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.